Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer

Name: Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
License: Public Domain

Washington University School of Medicine

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic hormone-sensitive prostate cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 623505
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.